{"transactions":[{"id":3099210,"issuer":{"id":8539,"kind":"organization","name":"CANNAPHARMARX, INC."},"owners":[{"id":42473,"kind":"person","name":"SAMUELSON JAMES F","position":1,"cik":"0001198070","reported_name":"SAMUELSON JAMES F","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Convertible Preferred Stock","published_at":"2020-06-26T17:26:02.000Z","date":"2018-04-20","kind":"other","acquired":true,"shares":10000,"price":1,"value":10000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The Reporting Person subscribed and paid for 30,000 Series A Convertible Preferred Shares directly from the Issuer. Subsequently, he verbally agreed to sell 10,000 of these shares, but the buyer failed to pay for the shares and the agreement was terminated."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The conversion righes of the Series A Convertible Preferred Stock do not expire and can be converted at any time."}],"balance_after":31000000,"derivative":{"exercise_price":0,"exercise_date":"2018-04-20","underlying":"Common Stock","underlying_shares":12500000},"source":{"system":"sec-edgar","filing":"0001683168-20-002077","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1081938/000168316820002077/ownership.xml","form_type":"4"}},{"id":3104580,"issuer":{"id":8539,"kind":"organization","name":"CANNAPHARMARX, INC."},"owners":[{"id":126256,"kind":"person","name":"Nicosia Matthew","position":1,"cik":"0001452672","reported_name":"Nicosia Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred","published_at":"2020-06-19T15:22:44.000Z","date":"2018-04-20","kind":"other","acquired":false,"shares":10000,"price":1,"value":10000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The Reporting Person subscribed and paid for 30,000 Series A Convertible Preferred Shares directly from the Issuer. Subsequently, he verbally agreed to sell 10,000 of these shares, but the buyer failed to pay for the shares and the agreement was terminated."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The conversion rights of the Series A Convertible Preferred Stock do not expire and can be exercised at any time."}],"balance_after":26000,"derivative":{"exercise_price":0,"exercise_date":"2018-06-17","underlying":"Common Stock","underlying_shares":12500000},"source":{"system":"sec-edgar","filing":"0001683168-20-002002","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1081938/000168316820002002/ownership.xml","form_type":"4"}},{"id":3104579,"issuer":{"id":8539,"kind":"organization","name":"CANNAPHARMARX, INC."},"owners":[{"id":126256,"kind":"person","name":"Nicosia Matthew","position":1,"cik":"0001452672","reported_name":"Nicosia Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred","published_at":"2020-06-19T15:22:44.000Z","date":"2019-06-17","kind":"sale","acquired":false,"shares":4000,"price":1,"value":4000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The conversion rights of the Series A Convertible Preferred Stock do not expire and can be exercised at any time."}],"balance_after":16000,"derivative":{"exercise_price":0,"exercise_date":"2018-04-20","underlying":"Common Stock","underlying_shares":5000000},"source":{"system":"sec-edgar","filing":"0001683168-20-002002","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1081938/000168316820002002/ownership.xml","form_type":"4"}},{"id":3167640,"issuer":{"id":8539,"kind":"organization","name":"CANNAPHARMARX, INC."},"owners":[{"id":149617,"kind":"person","name":"Colvin Dominic","position":1,"cik":"0001493405","reported_name":"Colvin Dominic","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-04-29T23:40:35.000Z","date":"2019-10-08","kind":"sale","acquired":false,"shares":1000000,"price":0.25,"value":250000.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Shares are held in the name of PLC International Investments, Inc. of which Reporting Person is the 100% owner and thus the control person having dispositive powers over\nthe shares. On October 2, 2019, Reporting Person personally loaned the Issuer $250,000 evidenced by Promissory Note utilizing funds from this sale."}],"balance_after":6988963,"source":{"system":"sec-edgar","filing":"0001683168-20-001345","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1081938/000168316820001345/ownership.xml","form_type":"4"}},{"id":3295262,"issuer":{"id":8539,"kind":"organization","name":"CANNAPHARMARX, INC."},"owners":[{"id":42473,"kind":"person","name":"SAMUELSON JAMES F","position":1,"cik":"0001198070","reported_name":"SAMUELSON JAMES F","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Convertible Preferred Stock","published_at":"2020-02-03T23:19:32.000Z","date":"2019-04-23","kind":"sale","acquired":false,"shares":1200,"price":1,"value":1200.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each share of the Series A Convertible Preferred Stock are convertible into 1,250 shares of Common Stock of the Issuer."},{"field":"shares","element":"transactionShares","label":"F3","text":"These shares were sold to the Company's Vice-President of Strategic Development and its legal counsel, respectively."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The conversion rights of the Series A Convertible Preferred Stock do not expire and can be exercised at any time."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Each share of the Series A Convertible Preferred Stock are convertible into 1,250 shares of Common Stock of the Issuer."}],"balance_after":14800,"derivative":{"exercise_price":0,"exercise_date":"2019-04-23","underlying":"Common Stock","underlying_shares":1500000},"source":{"system":"sec-edgar","filing":"0001683168-20-000334","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1081938/000168316820000334/ownership.xml","form_type":"4/A","original_submission_date":"2020-02-03"}},{"id":3295261,"issuer":{"id":8539,"kind":"organization","name":"CANNAPHARMARX, INC."},"owners":[{"id":42473,"kind":"person","name":"SAMUELSON JAMES F","position":1,"cik":"0001198070","reported_name":"SAMUELSON JAMES F","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Convertible Preferred Stock","published_at":"2020-02-03T23:19:32.000Z","date":"2019-04-23","kind":"sale","acquired":false,"shares":4000,"price":1,"value":4000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each share of the Series A Convertible Preferred Stock are convertible into 1,250 shares of Common Stock of the Issuer."},{"field":"shares","element":"transactionShares","label":"F3","text":"These shares were sold to the Company's Vice-President of Strategic Development and its legal counsel, respectively."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The conversion rights of the Series A Convertible Preferred Stock do not expire and can be exercised at any time."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Each share of the Series A Convertible Preferred Stock are convertible into 1,250 shares of Common Stock of the Issuer."}],"balance_after":16000,"derivative":{"exercise_price":0,"exercise_date":"2019-04-23","underlying":"Common Stock","underlying_shares":5000000},"source":{"system":"sec-edgar","filing":"0001683168-20-000334","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1081938/000168316820000334/ownership.xml","form_type":"4/A","original_submission_date":"2020-02-03"}},{"id":3295255,"issuer":{"id":8539,"kind":"organization","name":"CANNAPHARMARX, INC."},"owners":[{"id":42473,"kind":"person","name":"SAMUELSON JAMES F","position":1,"cik":"0001198070","reported_name":"SAMUELSON JAMES F","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Convertible Preferred Stock","published_at":"2020-02-03T21:55:38.000Z","date":"2018-04-23","kind":"sale","acquired":false,"shares":1200,"price":1,"value":1200.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each share of the Series A Convertible Preferred Stock are convertible into 1,250 shares of Common Stock of the Issuer."},{"field":"shares","element":"transactionShares","label":"F3","text":"These shares were sold to the Company's Vice-President of Strategic Development and its legal counsel, respectively."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The conversion rights of the Series A Convertible Preferred Stock do not expire and can be exercised at any time."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Each share of the Series A Convertible Preferred Stock are convertible into 1,250 shares of Common Stock of the Issuer."}],"balance_after":14800,"derivative":{"exercise_price":0,"exercise_date":"2018-04-20","underlying":"Common Stoc","underlying_shares":1500000},"source":{"system":"sec-edgar","filing":"0001683168-20-000325","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1081938/000168316820000325/ownership.xml","form_type":"4"}},{"id":3295254,"issuer":{"id":8539,"kind":"organization","name":"CANNAPHARMARX, INC."},"owners":[{"id":42473,"kind":"person","name":"SAMUELSON JAMES F","position":1,"cik":"0001198070","reported_name":"SAMUELSON JAMES F","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Convertible Preferred Stock","published_at":"2020-02-03T21:55:38.000Z","date":"2018-04-23","kind":"sale","acquired":false,"shares":4000,"price":1,"value":4000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each share of the Series A Convertible Preferred Stock are convertible into 1,250 shares of Common Stock of the Issuer."},{"field":"shares","element":"transactionShares","label":"F3","text":"These shares were sold to the Company's Vice-President of Strategic Development and its legal counsel, respectively."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The conversion rights of the Series A Convertible Preferred Stock do not expire and can be exercised at any time."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Each share of the Series A Convertible Preferred Stock are convertible into 1,250 shares of Common Stock of the Issuer."}],"balance_after":16000,"derivative":{"exercise_price":0,"exercise_date":"2018-04-20","underlying":"Common Stoc","underlying_shares":5000000},"source":{"system":"sec-edgar","filing":"0001683168-20-000325","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1081938/000168316820000325/ownership.xml","form_type":"4"}},{"id":3552959,"issuer":{"id":8539,"kind":"organization","name":"CANNAPHARMARX, INC."},"owners":[{"id":158279,"kind":"person","name":"Herick Gary J","position":1,"cik":"0001618233","reported_name":"Herick Gary J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-04-18T13:20:23.000Z","date":"2015-12-14","kind":"sale","acquired":false,"shares":35000,"price":1,"value":35000.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Through spouse who is a manager and control person of Whitemoon Energy."}],"balance_after":202000,"source":{"system":"sec-edgar","filing":"0001128732-19-000011","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1081938/000112873219000011/primary_doc.xml","form_type":"4"}},{"id":3552958,"issuer":{"id":8539,"kind":"organization","name":"CANNAPHARMARX, INC."},"owners":[{"id":158279,"kind":"person","name":"Herick Gary J","position":1,"cik":"0001618233","reported_name":"Herick Gary J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-04-18T13:20:23.000Z","date":"2015-08-11","kind":"sale","acquired":false,"shares":10000,"price":1,"value":10000.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Through spouse who is a manager and control person of Whitemoon Energy."}],"balance_after":237000,"source":{"system":"sec-edgar","filing":"0001128732-19-000011","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1081938/000112873219000011/primary_doc.xml","form_type":"4"}},{"id":3552957,"issuer":{"id":8539,"kind":"organization","name":"CANNAPHARMARX, INC."},"owners":[{"id":158279,"kind":"person","name":"Herick Gary J","position":1,"cik":"0001618233","reported_name":"Herick Gary J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-04-18T13:20:23.000Z","date":"2015-08-11","kind":"sale","acquired":false,"shares":3000,"price":1,"value":3000.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Through spouse who is a manager and control person of Whitemoon Energy."}],"balance_after":247000,"source":{"system":"sec-edgar","filing":"0001128732-19-000011","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1081938/000112873219000011/primary_doc.xml","form_type":"4"}},{"id":3552956,"issuer":{"id":8539,"kind":"organization","name":"CANNAPHARMARX, INC."},"owners":[{"id":158279,"kind":"person","name":"Herick Gary J","position":1,"cik":"0001618233","reported_name":"Herick Gary J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-04-18T13:20:23.000Z","date":"2015-05-11","kind":"sale","acquired":false,"shares":25000,"price":1,"value":25000.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Through spouse who is a manager and control person of Whitemoon Energy."}],"balance_after":250000,"source":{"system":"sec-edgar","filing":"0001128732-19-000011","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1081938/000112873219000011/primary_doc.xml","form_type":"4"}},{"id":3552955,"issuer":{"id":8539,"kind":"organization","name":"CANNAPHARMARX, INC."},"owners":[{"id":158279,"kind":"person","name":"Herick Gary J","position":1,"cik":"0001618233","reported_name":"Herick Gary J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-04-18T13:20:23.000Z","date":"2015-04-14","kind":"sale","acquired":false,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Through spouse who is a manager and control person of Whitemoon Energy."}],"balance_after":275000,"source":{"system":"sec-edgar","filing":"0001128732-19-000011","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1081938/000112873219000011/primary_doc.xml","form_type":"4"}},{"id":3554409,"issuer":{"id":8539,"kind":"organization","name":"CANNAPHARMARX, INC."},"owners":[{"id":158279,"kind":"person","name":"Herick Gary J","position":1,"cik":"0001618233","reported_name":"Herick Gary J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Series A Convertible Preferred Stock","published_at":"2019-04-17T17:24:33.000Z","date":"2018-04-20","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Held in the name of Arrowhead Consulting, LLC of which Reporting Person is a manager and control person."}],"balance_after":20000,"derivative":{"exercise_price":0,"exercise_date":"2018-04-20","expiration_date":"2023-04-20","underlying":"Common Stock","underlying_shares":25000000},"source":{"system":"sec-edgar","filing":"0001128732-19-000010","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":28,"url":"https://www.sec.gov/Archives/edgar/data/1081938/000112873219000010/primary_doc.xml","form_type":"4"}},{"id":3554408,"issuer":{"id":8539,"kind":"organization","name":"CANNAPHARMARX, INC."},"owners":[{"id":158279,"kind":"person","name":"Herick Gary J","position":1,"cik":"0001618233","reported_name":"Herick Gary J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-04-17T17:24:33.000Z","date":"2019-01-02","kind":"purchase","acquired":true,"shares":100000,"price":2,"value":200000.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Held in the name of Arrowhead Consulting, LLC of which Reporting Person is a manager and control person."}],"balance_after":600000,"source":{"system":"sec-edgar","filing":"0001128732-19-000010","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":27,"url":"https://www.sec.gov/Archives/edgar/data/1081938/000112873219000010/primary_doc.xml","form_type":"4"}},{"id":3554407,"issuer":{"id":8539,"kind":"organization","name":"CANNAPHARMARX, INC."},"owners":[{"id":158279,"kind":"person","name":"Herick Gary J","position":1,"cik":"0001618233","reported_name":"Herick Gary J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-04-17T17:24:33.000Z","date":"2019-01-02","kind":"purchase","acquired":true,"shares":100000,"price":2,"value":200000.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Held in the name of Arrowhead Consulting, LLC of which Reporting Person is a manager and control person."}],"balance_after":500000,"source":{"system":"sec-edgar","filing":"0001128732-19-000010","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":26,"url":"https://www.sec.gov/Archives/edgar/data/1081938/000112873219000010/primary_doc.xml","form_type":"4"}},{"id":3554406,"issuer":{"id":8539,"kind":"organization","name":"CANNAPHARMARX, INC."},"owners":[{"id":158279,"kind":"person","name":"Herick Gary J","position":1,"cik":"0001618233","reported_name":"Herick Gary J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-04-17T17:24:33.000Z","date":"2019-01-02","kind":"purchase","acquired":true,"shares":400000,"price":2,"value":800000.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Held in the name of Arrowhead Consulting, LLC of which Reporting Person is a manager and control person."}],"balance_after":400000,"source":{"system":"sec-edgar","filing":"0001128732-19-000010","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":25,"url":"https://www.sec.gov/Archives/edgar/data/1081938/000112873219000010/primary_doc.xml","form_type":"4"}},{"id":3554405,"issuer":{"id":8539,"kind":"organization","name":"CANNAPHARMARX, INC."},"owners":[{"id":158279,"kind":"person","name":"Herick Gary J","position":1,"cik":"0001618233","reported_name":"Herick Gary J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-04-17T17:24:33.000Z","date":"2018-06-27","kind":"sale","acquired":false,"shares":40000,"price":0.5,"value":20000.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Held in the name of Arrowhead Consulting, LLC of which Reporting Person is a manager and control person."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001128732-19-000010","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":24,"url":"https://www.sec.gov/Archives/edgar/data/1081938/000112873219000010/primary_doc.xml","form_type":"4"}},{"id":3554404,"issuer":{"id":8539,"kind":"organization","name":"CANNAPHARMARX, INC."},"owners":[{"id":158279,"kind":"person","name":"Herick Gary J","position":1,"cik":"0001618233","reported_name":"Herick Gary J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-04-17T17:24:33.000Z","date":"2018-06-27","kind":"sale","acquired":false,"shares":123500,"price":0.5,"value":61750.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Held in the name of Arrowhead Consulting, LLC of which Reporting Person is a manager and control person."}],"balance_after":40000,"source":{"system":"sec-edgar","filing":"0001128732-19-000010","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":23,"url":"https://www.sec.gov/Archives/edgar/data/1081938/000112873219000010/primary_doc.xml","form_type":"4"}},{"id":3554403,"issuer":{"id":8539,"kind":"organization","name":"CANNAPHARMARX, INC."},"owners":[{"id":158279,"kind":"person","name":"Herick Gary J","position":1,"cik":"0001618233","reported_name":"Herick Gary J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-04-17T17:24:33.000Z","date":"2018-06-27","kind":"sale","acquired":false,"shares":50000,"price":0.5,"value":25000.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Held in the name of Arrowhead Consulting, LLC of which Reporting Person is a manager and control person."}],"balance_after":163500,"source":{"system":"sec-edgar","filing":"0001128732-19-000010","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":22,"url":"https://www.sec.gov/Archives/edgar/data/1081938/000112873219000010/primary_doc.xml","form_type":"4"}},{"id":3554402,"issuer":{"id":8539,"kind":"organization","name":"CANNAPHARMARX, INC."},"owners":[{"id":158279,"kind":"person","name":"Herick Gary J","position":1,"cik":"0001618233","reported_name":"Herick Gary J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-04-17T17:24:33.000Z","date":"2018-06-27","kind":"sale","acquired":false,"shares":2000,"price":0.5,"value":1000.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Held in the name of Arrowhead Consulting, LLC of which Reporting Person is a manager and control person."}],"balance_after":213500,"source":{"system":"sec-edgar","filing":"0001128732-19-000010","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/1081938/000112873219000010/primary_doc.xml","form_type":"4"}},{"id":3554401,"issuer":{"id":8539,"kind":"organization","name":"CANNAPHARMARX, INC."},"owners":[{"id":158279,"kind":"person","name":"Herick Gary J","position":1,"cik":"0001618233","reported_name":"Herick Gary J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-04-17T17:24:33.000Z","date":"2018-06-27","kind":"sale","acquired":false,"shares":2000,"price":0.5,"value":1000.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Held in the name of Arrowhead Consulting, LLC of which Reporting Person is a manager and control person."}],"balance_after":215500,"source":{"system":"sec-edgar","filing":"0001128732-19-000010","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1081938/000112873219000010/primary_doc.xml","form_type":"4"}},{"id":3554400,"issuer":{"id":8539,"kind":"organization","name":"CANNAPHARMARX, INC."},"owners":[{"id":158279,"kind":"person","name":"Herick Gary J","position":1,"cik":"0001618233","reported_name":"Herick Gary J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-04-17T17:24:33.000Z","date":"2018-06-27","kind":"sale","acquired":false,"shares":3000,"price":0.5,"value":1500.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Held in the name of Arrowhead Consulting, LLC of which Reporting Person is a manager and control person."}],"balance_after":217500,"source":{"system":"sec-edgar","filing":"0001128732-19-000010","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1081938/000112873219000010/primary_doc.xml","form_type":"4"}},{"id":3554399,"issuer":{"id":8539,"kind":"organization","name":"CANNAPHARMARX, INC."},"owners":[{"id":158279,"kind":"person","name":"Herick Gary J","position":1,"cik":"0001618233","reported_name":"Herick Gary J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-04-17T17:24:33.000Z","date":"2018-06-27","kind":"sale","acquired":false,"shares":3000,"price":0.5,"value":1500.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Held in the name of Arrowhead Consulting, LLC of which Reporting Person is a manager and control person."}],"balance_after":220500,"source":{"system":"sec-edgar","filing":"0001128732-19-000010","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1081938/000112873219000010/primary_doc.xml","form_type":"4"}},{"id":3554398,"issuer":{"id":8539,"kind":"organization","name":"CANNAPHARMARX, INC."},"owners":[{"id":158279,"kind":"person","name":"Herick Gary J","position":1,"cik":"0001618233","reported_name":"Herick Gary J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-04-17T17:24:33.000Z","date":"2018-06-27","kind":"sale","acquired":false,"shares":2500,"price":0.5,"value":1250.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Held in the name of Arrowhead Consulting, LLC of which Reporting Person is a manager and control person."}],"balance_after":223500,"source":{"system":"sec-edgar","filing":"0001128732-19-000010","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1081938/000112873219000010/primary_doc.xml","form_type":"4"}},{"id":3554397,"issuer":{"id":8539,"kind":"organization","name":"CANNAPHARMARX, INC."},"owners":[{"id":158279,"kind":"person","name":"Herick Gary J","position":1,"cik":"0001618233","reported_name":"Herick Gary J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-04-17T17:24:33.000Z","date":"2015-12-15","kind":"sale","acquired":false,"shares":30000,"price":1,"value":30000.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Held in the name of Arrowhead Consulting, LLC of which Reporting Person is a manager and control person."}],"balance_after":226000,"source":{"system":"sec-edgar","filing":"0001128732-19-000010","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1081938/000112873219000010/primary_doc.xml","form_type":"4"}},{"id":3554396,"issuer":{"id":8539,"kind":"organization","name":"CANNAPHARMARX, INC."},"owners":[{"id":158279,"kind":"person","name":"Herick Gary J","position":1,"cik":"0001618233","reported_name":"Herick Gary J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-04-17T17:24:33.000Z","date":"2015-12-15","kind":"sale","acquired":false,"shares":100000,"price":0.75,"value":75000.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Held in the name of Arrowhead Consulting, LLC of which Reporting Person is a manager and control person."}],"balance_after":256000,"source":{"system":"sec-edgar","filing":"0001128732-19-000010","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1081938/000112873219000010/primary_doc.xml","form_type":"4"}},{"id":3554395,"issuer":{"id":8539,"kind":"organization","name":"CANNAPHARMARX, INC."},"owners":[{"id":158279,"kind":"person","name":"Herick Gary J","position":1,"cik":"0001618233","reported_name":"Herick Gary J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-04-17T17:24:33.000Z","date":"2015-12-15","kind":"sale","acquired":false,"shares":100000,"price":1,"value":100000.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Held in the name of Arrowhead Consulting, LLC of which Reporting Person is a manager and control person."}],"balance_after":356000,"source":{"system":"sec-edgar","filing":"0001128732-19-000010","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1081938/000112873219000010/primary_doc.xml","form_type":"4"}},{"id":3554394,"issuer":{"id":8539,"kind":"organization","name":"CANNAPHARMARX, INC."},"owners":[{"id":158279,"kind":"person","name":"Herick Gary J","position":1,"cik":"0001618233","reported_name":"Herick Gary J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-04-17T17:24:33.000Z","date":"2015-08-11","kind":"sale","acquired":false,"shares":15000,"price":1,"value":15000.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Held in the name of Arrowhead Consulting, LLC of which Reporting Person is a manager and control person."}],"balance_after":456000,"source":{"system":"sec-edgar","filing":"0001128732-19-000010","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1081938/000112873219000010/primary_doc.xml","form_type":"4"}},{"id":3554393,"issuer":{"id":8539,"kind":"organization","name":"CANNAPHARMARX, INC."},"owners":[{"id":158279,"kind":"person","name":"Herick Gary J","position":1,"cik":"0001618233","reported_name":"Herick Gary J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-04-17T17:24:33.000Z","date":"2015-08-11","kind":"sale","acquired":false,"shares":25000,"price":1,"value":25000.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Held in the name of Arrowhead Consulting, LLC of which Reporting Person is a manager and control person."}],"balance_after":471000,"source":{"system":"sec-edgar","filing":"0001128732-19-000010","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1081938/000112873219000010/primary_doc.xml","form_type":"4"}},{"id":3554392,"issuer":{"id":8539,"kind":"organization","name":"CANNAPHARMARX, INC."},"owners":[{"id":158279,"kind":"person","name":"Herick Gary J","position":1,"cik":"0001618233","reported_name":"Herick Gary J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-04-17T17:24:33.000Z","date":"2015-08-11","kind":"gift","acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Held in the name of Arrowhead Consulting, LLC of which Reporting Person is a manager and control person."}],"balance_after":496000,"source":{"system":"sec-edgar","filing":"0001128732-19-000010","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1081938/000112873219000010/primary_doc.xml","form_type":"4"}},{"id":3554391,"issuer":{"id":8539,"kind":"organization","name":"CANNAPHARMARX, INC."},"owners":[{"id":158279,"kind":"person","name":"Herick Gary J","position":1,"cik":"0001618233","reported_name":"Herick Gary J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-04-17T17:24:33.000Z","date":"2015-08-11","kind":"sale","acquired":false,"shares":3000,"price":1,"value":3000.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Held in the name of Arrowhead Consulting, LLC of which Reporting Person is a manager and control person."}],"balance_after":499000,"source":{"system":"sec-edgar","filing":"0001128732-19-000010","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1081938/000112873219000010/primary_doc.xml","form_type":"4"}},{"id":3554390,"issuer":{"id":8539,"kind":"organization","name":"CANNAPHARMARX, INC."},"owners":[{"id":158279,"kind":"person","name":"Herick Gary J","position":1,"cik":"0001618233","reported_name":"Herick Gary J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-04-17T17:24:33.000Z","date":"2015-08-11","kind":"gift","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Held in the name of Arrowhead Consulting, LLC of which Reporting Person is a manager and control person."}],"balance_after":502000,"source":{"system":"sec-edgar","filing":"0001128732-19-000010","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1081938/000112873219000010/primary_doc.xml","form_type":"4"}},{"id":3554389,"issuer":{"id":8539,"kind":"organization","name":"CANNAPHARMARX, INC."},"owners":[{"id":158279,"kind":"person","name":"Herick Gary J","position":1,"cik":"0001618233","reported_name":"Herick Gary J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-04-17T17:24:33.000Z","date":"2015-08-11","kind":"sale","acquired":false,"shares":25000,"price":1,"value":25000.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Held in the name of Arrowhead Consulting, LLC of which Reporting Person is a manager and control person."}],"balance_after":512000,"source":{"system":"sec-edgar","filing":"0001128732-19-000010","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1081938/000112873219000010/primary_doc.xml","form_type":"4"}},{"id":3554388,"issuer":{"id":8539,"kind":"organization","name":"CANNAPHARMARX, INC."},"owners":[{"id":158279,"kind":"person","name":"Herick Gary J","position":1,"cik":"0001618233","reported_name":"Herick Gary J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-04-17T17:24:33.000Z","date":"2015-07-31","kind":"sale","acquired":false,"shares":3000,"price":1,"value":3000.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Held in the name of Arrowhead Consulting, LLC of which Reporting Person is a manager and control person."}],"balance_after":537000,"source":{"system":"sec-edgar","filing":"0001128732-19-000010","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1081938/000112873219000010/primary_doc.xml","form_type":"4"}},{"id":3554387,"issuer":{"id":8539,"kind":"organization","name":"CANNAPHARMARX, INC."},"owners":[{"id":158279,"kind":"person","name":"Herick Gary J","position":1,"cik":"0001618233","reported_name":"Herick Gary J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-04-17T17:24:33.000Z","date":"2015-07-27","kind":"sale","acquired":false,"shares":10000,"price":1,"value":10000.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Held in the name of Arrowhead Consulting, LLC of which Reporting Person is a manager and control person."}],"balance_after":540000,"source":{"system":"sec-edgar","filing":"0001128732-19-000010","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1081938/000112873219000010/primary_doc.xml","form_type":"4"}},{"id":3554386,"issuer":{"id":8539,"kind":"organization","name":"CANNAPHARMARX, INC."},"owners":[{"id":158279,"kind":"person","name":"Herick Gary J","position":1,"cik":"0001618233","reported_name":"Herick Gary J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-04-17T17:24:33.000Z","date":"2015-07-10","kind":"sale","acquired":false,"shares":50000,"price":1,"value":50000.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Held in the name of Arrowhead Consulting, LLC of which Reporting Person is a manager and control person."}],"balance_after":550000,"source":{"system":"sec-edgar","filing":"0001128732-19-000010","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1081938/000112873219000010/primary_doc.xml","form_type":"4"}},{"id":3554385,"issuer":{"id":8539,"kind":"organization","name":"CANNAPHARMARX, INC."},"owners":[{"id":158279,"kind":"person","name":"Herick Gary J","position":1,"cik":"0001618233","reported_name":"Herick Gary J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-04-17T17:24:33.000Z","date":"2015-05-03","kind":"gift","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Held in the name of Arrowhead Consulting, LLC of which Reporting Person is a manager and control person."}],"balance_after":600000,"source":{"system":"sec-edgar","filing":"0001128732-19-000010","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1081938/000112873219000010/primary_doc.xml","form_type":"4"}},{"id":3554384,"issuer":{"id":8539,"kind":"organization","name":"CANNAPHARMARX, INC."},"owners":[{"id":158279,"kind":"person","name":"Herick Gary J","position":1,"cik":"0001618233","reported_name":"Herick Gary J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-04-17T17:24:33.000Z","date":"2015-05-03","kind":"gift","acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Held in the name of Arrowhead Consulting, LLC of which Reporting Person is a manager and control person."}],"balance_after":610000,"source":{"system":"sec-edgar","filing":"0001128732-19-000010","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1081938/000112873219000010/primary_doc.xml","form_type":"4"}},{"id":3554383,"issuer":{"id":8539,"kind":"organization","name":"CANNAPHARMARX, INC."},"owners":[{"id":158279,"kind":"person","name":"Herick Gary J","position":1,"cik":"0001618233","reported_name":"Herick Gary J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-04-17T17:24:33.000Z","date":"2015-05-03","kind":"gift","acquired":false,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Held in the name of Arrowhead Consulting, LLC of which Reporting Person is a manager and control person."}],"balance_after":660000,"source":{"system":"sec-edgar","filing":"0001128732-19-000010","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1081938/000112873219000010/primary_doc.xml","form_type":"4"}},{"id":3554382,"issuer":{"id":8539,"kind":"organization","name":"CANNAPHARMARX, INC."},"owners":[{"id":158279,"kind":"person","name":"Herick Gary J","position":1,"cik":"0001618233","reported_name":"Herick Gary J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-04-17T17:24:33.000Z","date":"2015-03-09","kind":"sale","acquired":false,"shares":50000,"price":1,"value":50000.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Held in the name of Arrowhead Consulting, LLC of which Reporting Person is a manager and control person."}],"balance_after":860000,"source":{"system":"sec-edgar","filing":"0001128732-19-000010","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1081938/000112873219000010/primary_doc.xml","form_type":"4"}},{"id":3555263,"issuer":{"id":8539,"kind":"organization","name":"CANNAPHARMARX, INC."},"owners":[{"id":158279,"kind":"person","name":"Herick Gary J","position":1,"cik":"0001618233","reported_name":"Herick Gary J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2019-04-16T13:31:07.000Z","date":"2014-11-01","kind":"grant","acquired":true,"shares":750000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":750000,"derivative":{"exercise_price":1,"exercise_date":"2015-06-26","expiration_date":"2024-11-01","underlying":"Common Stock","underlying_shares":750000},"source":{"system":"sec-edgar","filing":"0001128732-19-000009","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1081938/000112873219000009/primary_doc.xml","form_type":"4/A","original_submission_date":"2015-07-13"}},{"id":3555262,"issuer":{"id":8539,"kind":"organization","name":"CANNAPHARMARX, INC."},"owners":[{"id":158279,"kind":"person","name":"Herick Gary J","position":1,"cik":"0001618233","reported_name":"Herick Gary J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-04-16T13:31:07.000Z","date":"2015-06-29","kind":"other","acquired":true,"shares":400000,"ownership":{"direct":false,"nature":"Through spouse who is a manager of Whitemoon Energy."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to the June 29, 2015 closing of the merger, all of the issued and outstanding common stock of CannaPharmaRX, Inc., a Colorado corporation, was converted into shares of common stock, par value $0.0001 per share,of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the June 29, 2015 closing of the merger, all of the issued and outstanding common stock of CannaPharmaRX, Inc., a Colorado corporation, was converted into shares of common stock, par value $0.0001 per share,of the Issuer."}],"balance_after":400000,"source":{"system":"sec-edgar","filing":"0001128732-19-000009","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1081938/000112873219000009/primary_doc.xml","form_type":"4/A","original_submission_date":"2015-07-13"}},{"id":3555261,"issuer":{"id":8539,"kind":"organization","name":"CANNAPHARMARX, INC."},"owners":[{"id":158279,"kind":"person","name":"Herick Gary J","position":1,"cik":"0001618233","reported_name":"Herick Gary J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-04-16T13:31:07.000Z","date":"2015-06-29","kind":"other","acquired":true,"shares":910000,"ownership":{"direct":false,"nature":"As a manager of Arrowhead Consulting."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to the June 29, 2015 closing of the merger, all of the issued and outstanding common stock of CannaPharmaRX, Inc., a Colorado corporation, was converted into shares of common stock, par value $0.0001 per share,of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the June 29, 2015 closing of the merger, all of the issued and outstanding common stock of CannaPharmaRX, Inc., a Colorado corporation, was converted into shares of common stock, par value $0.0001 per share,of the Issuer."}],"balance_after":910000,"source":{"system":"sec-edgar","filing":"0001128732-19-000009","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1081938/000112873219000009/primary_doc.xml","form_type":"4/A","original_submission_date":"2015-07-13"}},{"id":3555260,"issuer":{"id":8539,"kind":"organization","name":"CANNAPHARMARX, INC."},"owners":[{"id":158279,"kind":"person","name":"Herick Gary J","position":1,"cik":"0001618233","reported_name":"Herick Gary J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-04-16T13:31:07.000Z","date":"2015-06-29","kind":"other","acquired":true,"shares":600000,"ownership":{"direct":false,"nature":"Through spouse and family members."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to the June 29, 2015 closing of the merger, all of the issued and outstanding common stock of CannaPharmaRX, Inc., a Colorado corporation, was converted into shares of common stock, par value $0.0001 per share,of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the June 29, 2015 closing of the merger, all of the issued and outstanding common stock of CannaPharmaRX, Inc., a Colorado corporation, was converted into shares of common stock, par value $0.0001 per share,of the Issuer."}],"balance_after":600000,"source":{"system":"sec-edgar","filing":"0001128732-19-000009","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1081938/000112873219000009/primary_doc.xml","form_type":"4/A","original_submission_date":"2015-07-13"}},{"id":3555259,"issuer":{"id":8539,"kind":"organization","name":"CANNAPHARMARX, INC."},"owners":[{"id":158279,"kind":"person","name":"Herick Gary J","position":1,"cik":"0001618233","reported_name":"Herick Gary J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-04-16T13:31:07.000Z","date":"2015-06-29","kind":"other","acquired":true,"shares":340000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to the June 29, 2015 closing of the merger, all of the issued and outstanding common stock of CannaPharmaRX, Inc., a Colorado corporation, was converted into shares of common stock, par value $0.0001 per share,of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the June 29, 2015 closing of the merger, all of the issued and outstanding common stock of CannaPharmaRX, Inc., a Colorado corporation, was converted into shares of common stock, par value $0.0001 per share,of the Issuer."}],"balance_after":340000,"source":{"system":"sec-edgar","filing":"0001128732-19-000009","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1081938/000112873219000009/primary_doc.xml","form_type":"4/A","original_submission_date":"2015-07-13"}},{"id":3555258,"issuer":{"id":8539,"kind":"organization","name":"CANNAPHARMARX, INC."},"owners":[{"id":158279,"kind":"person","name":"Herick Gary J","position":1,"cik":"0001618233","reported_name":"Herick Gary J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-04-16T13:31:07.000Z","date":"2015-06-29","kind":"other","acquired":false,"shares":10421120,"ownership":{"direct":false,"nature":"Through CannaPharmaRX, Inc., a Coloradoo corporation, as an officer and director."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The 10,421,120 shares of common stock owned by CannaPharmaRX, Inc., a Colorado corporation, have been surrendered and retired to treasury stock of the Issuer pursuant to the June 29, 2015 closing of the merger contemplated by the Amended and Restated Agreement and Plan of Merger dated April 21, 2015."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The 10,421,120 shares of common stock owned by CannaPharmaRX, Inc., a Colorado corporation, have been surrendered and retired to treasury stock of the Issuer pursuant to the June 29, 2015 closing of the merger contemplated by the Amended and Restated Agreement and Plan of Merger dated April 21, 2015."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001128732-19-000009","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1081938/000112873219000009/primary_doc.xml","form_type":"4/A","original_submission_date":"2015-07-13"}}]}